Clinical Trial Update: Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist [Phase 3]

View source ↗

Summary

This document reports the completion and results of a Phase 3 efficacy and safety study of benralizumab in adults and adolescents with asthma inadequately contr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2017-01-25